Showing results (81-90 of 2,406) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|January 14, 2016
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in CanadaPeter Quon, Hoa H Le, Vincent Raymond, et al.Journal of Medical Economics|January 15, 2016
Rates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare systemNazia Rashid, Antony T Lin, Gustavus Aranda, et al.Journal of Medical Economics|October 29, 2014
Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic controlMarie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Gravel, et al.Journal of Medical Economics|September 15, 2015
Comparison of historical medical spending patterns among the BRICS and G7Mihajlo Michael JakovljevicJournal of Medical Economics|September 15, 2015
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospitalThomas S Y Chan, Stephen W Marcella, Harinder Gill, et al.Journal of Medical Economics|October 20, 2015
The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacyD Brixner, E Biltaji, A Bress, et al.Journal of Medical Economics|December 10, 2014
Economic evaluation of pharmacological treatments for overactive bladder from the perspective of the UK National Health ServiceJameel Nazir, John Posnett, Anna Walker, et al.Journal of Medical Economics|April 27, 2016
Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of JapanMasatsugu Hori, Shunya Ikeda, Ken Okumura, et al.Journal of Medical Economics|April 12, 2016
Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in FranceFrancis Fagnani, Thao Pham, Pascal Claudepierre, et al.Pageof 241